Trials / Unknown
UnknownNCT03728296
A Study of Autologous Induced Islet Body With Type 1 Diabetes
Clinical Study on the Safety and Efficacy of Autologous Induced Islet Body With Type 1 Diabetes
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Allife Medical Science and Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a single centre、single arm、open-label study，to investigate the safety and efficacy of Autologous induced islet body With Type 1 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | islet body | Transplanting islet bodies under the diaphragm |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-01-01
- Completion
- 2021-01-01
- First posted
- 2018-11-02
- Last updated
- 2018-11-02
Source: ClinicalTrials.gov record NCT03728296. Inclusion in this directory is not an endorsement.